WRAPUP 1-U.S. tightens COVID-19 travel rules as countries race to quell Omicron threat
The United States is moving to require that all air travellers entering the country show a negative COVID-19 test performed within one day of departure, the Centers for Disease Control and Prevention (CDC) said. Currently, vaccinated international travellers can present a negative test result obtained within three days from their point of departure.
- United States
Air travelers to the United States will face tougher COVID-19 testing rules as several countries moved to seal off their borders amid growing uncertainty around the virulence of the Omicron variant and its ability to dodge existing vaccines. In Asia-Pacific, Hong Kong and Japan said they would expand travel curbs, while Australia was bracing for more Omicron cases after at least two people visited several locations in its biggest city while likely infectious.
In an attempt to stave off hasty global border restrictions, the World Health Organization called on countries to apply "an evidence-informed and risk-based approach" to travel measures. Blanket travel bans will not prevent the spread, and they "place a heavy burden on lives and livelihoods", the WHO said. More than 50 countries were reportedly implementing travel measures aimed at potentially delaying import of Omicron as of Nov. 28, the WHO added.
Investors remained on edge on Wednesday, even as financial markets came off lows plumbed a day earlier following remarks by the CEO of Moderna that raised questions about the efficacy of COVID-19 vaccines against Omicron. Global health officials have since sought to offer reassurances and reiterated calls for people to get vaccinated.
"Even if the new variant becomes more widespread, the vaccines we have will continue to provide protection," European Medicines Agency Executive Director Emer Cooke said. Echoing remarks by vaccine maker BioNTech and scientists, Cooke said laboratory analyses should indicate over the next two weeks whether the blood of vaccinated people has sufficient antibodies to neutralize the new variant.
BioNTech's CEO said the vaccine it makes in a partnership with Pfizer would likely offer strong protection against severe disease from Omicron. BORDER CONTROLS
First reported in southern Africa a week ago, Omicron has triggered global alarm, led to travel bans, and highlighted the disparity between massive vaccination pushes in rich nations and sparse inoculation in the developing world. The United States is moving to require that all air travelers entering the country show a negative COVID-19 test performed within one day of departure, the Centers for Disease Control and Prevention (CDC) said.
Currently, vaccinated international travelers can present a negative test result obtained within three days from their point of departure. The new one-day testing requirement would apply equally to U.S. citizens as well as foreign nationals. The administration is also considering whether to require air travelers to get another test within three to five days after arrival in the United States, officials said.
While the CDC did not confirm that, it noted it continues to recommend all "travelers should get a COVID-19 viral test 3-5 days after arrival" and "post-travel quarantine for any unvaccinated travelers". The CDC lists about 80 foreign destinations as having "Level Four," its highest level of COVID-19 transmission, and discourages Americans from traveling to those destinations.
In Asia, Japan, which had already shut its borders to all newly entering foreigners, said it would expand its ban to foreigners with resident status from 10 African countries including South Africa. Hong Kong will expand its entry ban for non-residents to three more countries, Japan, Portugal, and Sweden, from Friday.
South Korean Interior and Safety Minister Jeon Hae-Cheol called for tighter virus prevention measures to head off Omicron after suspected cases entered Nigeria. The country has not reported any confirmed cases of the variant so far.
Global airlines are preparing for fresh volatility, analysts said, as Omicron could force them to adjust schedules and destinations at short notice and to rely more on domestic markets where possible. "It feels a little bit like we are back to where we were a year ago and that's not a great prospect for the industry and beyond," Deidre Fulton, a partner at consultancy MIDAS Aviation, said at an industry webinar.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)